(Q38369000)

2 September 2017

1 reference

title

Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer (English)

1 reference

2 September 2017

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Matteo Santoni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

F Massari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Marzia Del Re

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Francesco Piva

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Giovanni Principato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Romano Danesi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Giampaolo Tortora

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Stefano Cascinu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

7

Rodolfo Montironi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

4

Chiara Ciccarese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

7 March 2015

1 reference

Expert Opinion on Investigational Drugs

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

809-824

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Cytokine-induced slowing of STAT3 nuclear import; faster basal trafficking of the STAT3β isoform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Antitumorigenic potential of STAT3 alternative splicing modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Expression of the JAK and STAT superfamilies in human meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The role of STATs in myeloid differentiation and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Getting the message across, STAT! Design principles of a molecular signaling circuit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Transport into and out of the cell nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

A Novel Sequence in the Coiled-coil Domain of Stat3 Essential for Its Nuclear Translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT3 as a central mediator of neoplastic cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STATs dimerize in the absence of phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Regulation of Stat3 nuclear export

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Acetylation of Stat1 modulates NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

A phosphorylation-acetylation switch regulates STAT1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT3 inhibition of gluconeogenesis is downregulated by SirT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Cytokine signaling modules in inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Th1 and Th17 cells: adversaries and collaborators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Epidermal growth factor receptor (EGFR) signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The JAK-STAT pathway at twenty

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Sphingosine-1-phosphate: Driver of NFκB and STAT3 persistent activation in chronic intestinal inflammation and colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Interplay between microRNAs and the STAT3 signaling pathway in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Regulation of cortical actin networks in cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

AAG8 promotes carcinogenesis by activating STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Oncogenic roles of EMT-inducing transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Differential roles of STAT3 in the initiation and growth of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K/mTOR inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The role of signal transducers and activators of transcription in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Enzalutamide in metastatic prostate cancer before chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Increased survival with enzalutamide in prostate cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Investigational Janus kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Late type apoptosis and apoptosis free lethal effect of quercetin in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Revisiting STAT3 signalling in cancer: new and unexpected biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

The role of STAT3 signaling in mediating tumor resistance to cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1020370

10.1517/13543784.2015.1020370

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25746129%20AND%20SRC:MED&resulttype=core&format=json

release_epr6fapgsff55ev6b6mf7wfi3y

5 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/epr6fapgsff55ev6b6mf7wfi3y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference